Selected synthetic dipeptides and milk protein hydrolysates were evaluated for their dipeptidyl peptidase IV (DPP-IV) inhibitory properties, and their superoxide (SO) and 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging activities. DPP-IV inhibition was seen with eight out of the twelve dipeptides and 5 of the twelve hydrolysates studied. Trp-Val inhibited DPP-IV, however, inhibition was not observed with the reverse peptide Val-Trp. The most potent hydrolysate inhibitors were generated from casein (CasH2) and lactoferrin (LFH1). Two Trp containing dipeptides, Trp-Val and Val-Trp, and three lactoferrin hydrolysates scavenged DPPH. The dipeptides had higher SO EC 50 values compared to the milk protein hydrolysates (arising from three lactoferrin and one whey protein hydrolysates). Higher molecular mass fractions of the milk protein hydrolysates were associated with the SO scavenging activity. Trp-Val and one lactoferrin hydrolysate (LFH1) were multifunctional displaying both DPP-IV inhibitory and antioxidant (SO and DPPH scavenging) activities. These compounds may have potential as dietary ingredients in the management of type 2 diabetes by virtue of their ability to scavenge reactive oxygen species and to extend the half-life of incretin molecules.
Introduction
The worldwide incidence of type2 diabetes is increasing. It was estimated in 2000 that there were 171 million diabetics while incidences for 2030 are estimated to reach 366 million people [45] .
Different strategies have been developed to help in the management of type 2 diabetes; one of which is inhibition of dipeptidyl peptidase IV (DDP-IV). Incretins such as glucose dependent insulinotropic peptide (GIP) and more particularly glucagon-like peptide-1 (GLP-1) can enhance insulin secretion from pancreatic beta cells in the presence of glucose in vivo [2, 42] . However, GLP-1 and GIP can be degraded by DDP-IV, resulting in major losses in the bioactive properties of these incretins. DDP-IV is located at the surface of various cells and can also be found in a soluble form in the circulation [2] . An increase in circulating GLP-1 by a factor 4 to 6 has been reported in vivo following the utilization of DDP-IV drug inhibitors [27] . DDP-IV inhibitors are reported to protect GLP-1 and GIP from enzymatic degradation and therefore can increase their half-life, resulting in a prolonged action in vivo [2] . Peptide-like DDP-IV inhibitors such as vildagliptin and saxagliptin [17] have been shown to normalize blood glucose concentration in type 2 diabetic subjects [27] . However, contradictory results are also reported in the literature with some studies indicating no direct correlation between the insulinotropic properties of DDP-IV inhibitors and plasma GLP-1 levels. This suggests that other incretins and neuropeptides also play a role in the regulation of blood glucose homeostasis in the presence of DDP-IV inhibitors [27] .
Peptide inhibitors of DPP-IV having Xaa-Pro, Pro-Xaa or Xaa-Ala (with Xaa an amino acid residue) sequences have been reported in the literature [46] . Furthermore, various studies have highlighted the possibility of using food proteins as natural sources of DDP-IV inhibitory peptides. Milk proteins, particularly, milk protein-derived peptides and amino acids have also been linked with the regulation of postprandial glycaemia and insulin secretion in normoglycaemic and type 2 diabetic subjects [6, 8, 23, 24, 26, 32] . Peptides derived from -lactoglobulin have been shown to possess DDP-IV inhibitory activity in vitro [42, 43] .
Furthermore, the DDP-IV inhibitory peptide Leu-Pro-Glu-Arg-Ile-Pro-Pro-Leu from Gouda-type cheese induced a significant reduction of blood glucose in rats following a glucose challenge [44] . Similarly, a DPP-IV inhibitory tryptic digest of -lactoglobulin induced a decrease in blood glucose level in mice following an oral glucose tolerance test when administered orally at 300 mg/kg body weight [43] . More recently, an in silico approach has been utilized to identify potential dietary protein precursors of DDP-IV inhibitory peptides [18] .
In type 2 diabetic subjects, the natural antioxidant protective systems including superoxide dismutase, glutathione (GSH) peroxidase and catalase may be compromised due to an overall increase in oxidative stress. It is well recognized that cardiovascular and renal disease can develop as secondary complications in subjects suffering from type 2 diabetes and insulin resistance syndrome [10, 12] . Different studies have demonstrated the anti-oxidative potential of milk proteins and peptides [3, 20, 31, 36, 38, 41] . Whey protein hydrolysates can help decrease oxidative stress by their radical scavenging activity and by their ability to increase the production of antioxidant enzymes in vivo [13, 21, 31] . Similarly, caseins and casein-derived peptides have been associated with radical-scavenging properties in vitro [1, 9, 15, 41] and with their ability to increase cellular catalase activity and GSH levels in human lymphocyte (Jurkat) cells [30] . More recently we have reported on two dipeptides, Val-Trp and Val-Trp, and different lactoferrin hydrolysates which can inhibit xanthine oxidase (XO) in vitro [28] .
The aim of this study was to evaluate the potential of selected dipeptides for their antioxidant (SO and DPPH scavenging) activity and for their DDP-IV inhibitory properties. In addition, a range of milk protein hydrolysates was also evaluated for their antioxidant and DPP-IV inhibitory properties.
Material and methods

Reagents
The synthetic dipeptides Val-Trp, Trp-Val, Ala-Leu, Asp-Lys, Glu-Lys, Gly-Leu, Ser-Leu, SerPhe and Val-Ala were obtained from Bachem (Bubendorf, Switzerland) while Phe-Leu, His-Leu, 
Methods
Hydrolysis of milk protein substrates
Hydrolysis of the milk protein substrates was carried out with food-grade commercial gastrointestinal preparations essentially as described by Spellman et al. [39] . Five WP (WPH1 to WPH5), four Cas (CasH1 to CasH4) and three LF (LFH1 to LFH3) hydrolysates were manufactured. The starting milk protein substrates were suspended at 10 % (w/w) on a protein basis in water and dispersed under agitation at 50C for 1 h using an overhead stirrer (Heidolph RZR 1, Germany) and hydrolysed at 50°C for 240 min. A control sample without enzyme was removed from the protein dispersion and maintained at 50°C for the duration of the hydrolysis reaction. The enzyme was inactivated by heating the hydrolysate samples at 90°C for 20 min.
Hydrolysates were freeze-dried (FreeZone 18L, Labconco, Kansas City, U.S.A.) and stored at -20°C until further analysis.
Reversed-phase ultra-performance liquid chromatography of milk protein hydrolysates
The starting substrates and corresponding hydrolysates were analysed by liquid chromatography using an ultra-performance liquid chromatograph (UPLC Acquity -Waters, Dublin, Ireland) as described by Nongonierma and FitzGerald [28] .
DPPH radical scavenging assay
The DPPH assay was used to determine the proton radical scavenging properties of the dipeptides and milk protein hydrolysates. 
Superoxide radical scavenging assay
The test samples (dipeptides and hydrolysates) were dispersed in HPLC grade water at concentrations ranging from 5.0 × 10 -3 to 1.0 mg.mL -1 . The superoxide (SO) scavenging assay was carried out following the method of Ewing and Janero [4] . 
DPP-IV inhibition assay
The test samples (dipeptides and hydrolysates) were dispersed in HPLC grade water at concentrations ranging from 12.5 × 10 -3 to 6.3 mg.mL -1 . The DPP-IV inhibition assay was carried out as described by Lacroix and Li-Chan [17] . Test samples (50L) were pipetted onto a 96 well microplate containing Gly-Pro-pNA, the reaction substrate (final concentration 0. 
Statistical analysis
Means comparison was carried out with a one way ANOVA followed by a Student Newman-Keuls test using SPSS (version 9, SPSS Inc., Chicago, IL, USA) at a significance level P < 0.05.
For the Lineweaver and Burk plots, experimental data was fitted by linear regression using SPSS.
Results
Superoxide scavenging activity of dipeptides and milk protein hydrolysates
Of the twelve dipeptides studied, scavenging activity for superoxide radicals was seen with nine dipeptides ( 
DPPH scavenging activity of dipeptides and milk protein hydrolysates
With the exception of Val-Trp and its reverse peptide Trp-Val, the different dipeptides studied showed no activity for scavenging of DPPH radicals ( Table 2 ). All 12 hydrolysates studied were able to scavenge DPPH radicals. However, this antioxidant activity was not higher than that of the unhydrolysed milk protein (negative control) with the exception of LF (data not shown). All three LF hydrolysates studied displayed a scavenging activity for DPPH radicals.
The EC 50 values determined for the LF hydrolysates were 5 to 10 times higher than that of Trp,
Val-Trp and Trp-Val (Table 2 ).
DPP-IV inhibition of dipeptides and milk protein hydrolysates
DPP-IV inhibition was seen with 8 of the dipeptides studied ( hydrolysates studied were able to inhibit DPP-IV. The most potent inhibitors were LFH1 and CasH2 (Table 3) , their comparative inhibitory activity was not significantly different (P ≥ 0.05). (Table   3 ).
Discussion
Power et al. [33] recently reviewed the antioxidant properties of peptides with a particular focus on milk-derived peptides and hydrolysates. Since reactive oxidative species (ROS) are found both in the intracellular and extracellular compartments within the human body, it is conceivable that different antioxidative peptide structures may function in these compartments. Low molecular mass peptides, such as carnosine (Ala-His) and GSH (Cys-Glu-Gly), have been shown to act as antioxidants within cells whereas larger molecular mass peptides (which may be present within hydrolysates) can display their antioxidative activity in the plasma [33] . [20] .
In addition, peptic hydrolysates of casein and casein derived-peptides have been identified for their SO scavenging activity [41] . A potent scavenger of SO radicals has been isolated from a peptic digest of casein with the peptide structure Tyr-Pro-Tyr-Pro-Glu-Leu [41] . Removal of the amino acids at the N terminal position (Tyr, Tyr-Pro or Tyr-Pro-Tyr residues) of this peptide resulted in a reduction of the SO scavenging activity. However, bioactivity was restored with the dipeptide Glu-Leu [41] . In comparison with dipeptides, milk protein hydrolysates exhibited higher SO scavenging activities on a weight basis, showing lower EC 50 values than the dipeptides (Table 1) . More potent SO scavenger peptides than the ones studied may be present within these milk protein hydrolysates. Upon fractionation of a peptic casein hydrolysate, three fractions with a wide range of EC 50 values from less than 0.1 to greater than 10 mg.mL -1 have been identified [41] . This suggests that potent SO scavengers can be found within milk protein hydrolysates. In addition enrichment of bioactive peptides following fractionation could result in an increased potency for SO scavenging.
Various milk derived peptides have previously been reported for their DPPH radical scavenging activity [31, 34] To the best of our knowledge, this is the first time that these dipeptides have been described for their DPPH radical scavenging activity. It has previously been reported that the antioxidant activity of dipeptides depends on the C or N terminal position of certain amino acid residues with stronger antioxidant activity associated with Trp-Lys compared to Lys-Trp [40] . Similarly, in this study, the dipeptide with Trp at the N terminus (Trp-Val) was the most potent DPPH scavenger. Previous studies reported differences in other bioactivities for these two dipeptides. Val-Trp, a non-competitive angiotensin converting enzyme (ACE) inhibitor, had an ACE inhibition IC 50 value 200 times less than Trp-Val, a competitive inhibitor of ACE [29] . Free Trp also showed scavenging properties for DPPH, however, it was less potent than the dipeptide Trp-Val ( Table 2 ). The lower antioxidant activity observed for amino acids compared to peptides has been explained by their lower radical scavenging activity [3] . In silico analysis showed that theoretically, Val-Trp can be released from LF following digestion with gastrointestinal activities [28] . In agreement with these findings, the three LF hydrolysates evaluated showed scavenging activity for DPPH radicals.
Eight out of the twelve dipeptides studied herein were shown to be DPP-IV inhibitors (Table 3) .
To the best of our knowledge, some of the dipeptides described herein have not previously been reported as DPP-IV inhibitors. These include Trp-Val, Ala-Leu, Glu-Lys, Gly-Leu, Ser-Leu, PheLeu and His-Leu. The dipeptide Val-Ala has been identified in previous studies as an inhibitor for DPP-IV. This dipeptide occurs in different milk proteins including -, -and -casein, -lactoglobulin and LF [18] . The IC 50 values found for the dipeptides studied herein are of the same order as values reported in the literature for other DPP-IV inhibitory peptides. For example, an IC 50 of 46 M was found for Leu-Pro-Glu-Arg-Ile-Pro-Pro-Leu and other -casein peptides had an IC 50 value between 110 and 1500 M [44] . The most potent DPP-IV inhibitory peptide studied herein was Trp-Val (Table 3) . Surprisingly, the reverse peptide Val-Trp did not inhibit DPP-IV.
Similar findings as those for Val-Trp and its reverse peptide have been mentioned in another study, with Ile-Pro (IC 50 0.41 ± 0.07 M) inhibiting DPP-IV whereas its reverse peptide Pro-Ile did not [11] . This result was explained by the fact the N terminal residue of the peptide plays an important role in the inhibition of DPP-IV [11] . Different milk protein hydrolysates have been reported for their DPP-IV inhibitory potential including hydrolysates of-lactoglobulin [17, 43] .
Of 22 milk protein hydrolysates screened for their DPP-IV inhibitory potential, Lacroix and LiChan [17] found that casein hydrolysates were generally more potent than WP hydrolysates with the exception of a peptic whey protein hydrolysate. Out of 5 hydrolysates with DPP-IV inhibition herein, 2 were generated from Cas and WP and one from LF. The most potent hydrolysates in this study were LFH1 and CasH2 (Table 3 ). The higher potency of Cas hydrolysates has been linked to the fact that -casein is the milk protein substrate displaying the highest number of DPP-IV inhibitory peptide sequences (which is defined as the number of peptide sequences with DPP-IV inhibitory activity divided by the length of the protein) [18] . The DPP-IV IC 50 values observed for the milk protein hydrolysates described herein are of the same order as values reported in the literature. IC 50 values ranging from 0.075 to 6.4 ± 2.3 mg.mL -1 have previously been reported for various food protein-derived hydrolysates [11, 17, 19] . It is interesting to note that the milk protein hydrolysates were less potent on a weight basis than the dipeptides (Table   3 ). This may be explained by the fact that the bioactive peptides within the milk protein hydrolysates may be present at relatively low concentrations [17] . As expected, the RP-UPLC (Fig. 2) profiles of the hydrolysates studied differed, which indicates that the peptides involved in the bioactive properties determined within this study were different. All hydrolysates studied herein were competitive inhibitors of DPP-IV. Competitive inhibition suggested a direct interaction between the hydrolysates and DPP-IV. It has been suggested that some milk-derived peptides may also behave as DPP-IV substrates, resulting in a direct interaction of the peptide with the active site of the enzyme [17] . Similarly, most of the dipeptides were competitive DPP-IV inhibitors with the exception of Trp-Val which was non-competitive. Non-competitive inhibition of DPP-IV with peptides derived from the human immunodeficiency virus-1 (HIV)
transactivator Tat has been reported [22] . The non-competitive inhibition was due to peptides binding to a secondary site different from the active site of DPP-IV.
Trp-Val and the LF hydrolysate were both able to scavenge DPPH and SO radicals, and were also able to inhibit DPP-IV. To the best of our knowledge, this is the first time that an LF hydrolysate has been reported for its DPP-IV inhibitory activity. Trp-Val and LF hydrolysates have recently been described for their XO inhibitory properties [28] . This result is of interest as Trp-Val and LFH1 may act as multifunctional components which could modulate different targets beneficial, for example, in the management of type 2 diabetes. Intestinal transport of intact peptides and even proteins is reported to occur in vivo [7] . Hydrophobic short peptide sequences from milk such as Leu-Trp, Phe-Tyr and Ile-Tyr, Ile-Pro-Pro could reach the circulation without being degraded in the gastrointestinal tract [5] . Furthermore, dipeptides with hydrophobic characteristics such as Trp-Val may be bioavailable especially since hydrophobic peptides have been associated with a high trans-epithelial permeation through a caco-2 cell monolayer [37] .
Further studies are needed to validate that the in vitro bioactive properties described herein pertain in vivo.
Conclusion
Protein hydrolysates and dipeptides which can be released by the action of food-grade gastrointestinal enzyme preparations on milk proteins behave as scavengers of DPPH and superoxide radicals. In addition, eight dipeptides were shown to inhibit DPP-IV of which five could in theory be released by the action of gastro-intestinal enzyme activities on milk proteins.
An LF-derived hydrolysate (LFH1) and Trp-Val may act as multifunctional agents in the management of type 2 diabetes. Both components reduce oxidative species (SO and DPPH scavenging properties) and inhibit DPP-IV activity in vitro in a dose-dependent manner.
Identification of the peptides within the milk protein hydrolysates presented herein would help to better understand the origin of the DPP-IV inhibition properties of these food-grade hydrolysates.
Future in vivo studies on these components are required to validate the in vitro data and to confirm the bioavailability and bioactivity of these milk protein hydrolysates and dipeptides in humans. 
